| Mr Arturo Guzman, MD | |
|
1375 Vista Ln, Carson City, NV 89703 | |
| (775) 882-2067 | |
| Not Available |
| Full Name | Mr Arturo Guzman |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 11 Years |
| Location | 1375 Vista Ln, Carson City, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629310305 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 17996 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carson Tahoe Regional Medical Center | Carson city, NV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thomas King Halow Mds Ltd | 0547246415 | 5 |
News Archive
The researchers, funded by National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC), created the Mass Science app that allows COVID-Collab study participants to connect wearables, such as Fitbit devices, and share data including heart rate, activity and sleep.
GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' extensible low-level hierarchal architecture.
A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
| Entity Name | Thomas King Halow Mds Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750404182 PECOS PAC ID: 0547246415 Enrollment ID: O20040629001634 |
News Archive
The researchers, funded by National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC), created the Mass Science app that allows COVID-Collab study participants to connect wearables, such as Fitbit devices, and share data including heart rate, activity and sleep.
GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' extensible low-level hierarchal architecture.
A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Arturo Guzman, MD 1375 Vista Ln, Carson City, NV 89703-4643 Ph: (775) 882-2067 | Mr Arturo Guzman, MD 1375 Vista Ln, Carson City, NV 89703 Ph: (775) 882-2067 |
News Archive
The researchers, funded by National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre (BRC), created the Mass Science app that allows COVID-Collab study participants to connect wearables, such as Fitbit devices, and share data including heart rate, activity and sleep.
GeckoSystems Intl. Corp. announced today that during their first annual "Mobile Robots in Motion" conference November 4-5, 2009 attendees will be able to observe and discuss GeckoSystems' extensible low-level hierarchal architecture.
A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.
Acucela Inc., a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, and Otsuka Pharmaceutical Co., Ltd., today announced that they have received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ACU-4429, an investigational oral treatment for dry age-related macular degeneration (dry AMD).
› Verified 8 days ago
Dr. Andrew John Erickson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1375 Vista Ln, Carson City, NV 89703 Phone: 775-882-2067 Fax: 775-882-3706 | |
Kraig Allyn Knoll, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1761 College Pkwy Ste 112, Carson City, NV 89706 Phone: 775-882-8848 Fax: 775-882-8859 | |
Kevin D Halow, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1375 Vista Lane, Carson City, NV 89703 Phone: 775-882-2067 Fax: 775-882-3706 | |
Timothy J King, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1375 Vista Lane, Carson City, NV 89703 Phone: 775-882-2067 Fax: 775-882-3706 | |
William H Thomas, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1375 Vista Lane, Carson City, NV 89703 Phone: 775-882-2067 Fax: 775-882-3706 | |
Mark A. Demar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1761 College Pkwy Ste 112, Carson City, NV 89706 Phone: 775-684-9009 |